GlaxoSmithKline Pharmaceuticals LimitedShare price targets & analyst calls
₹2,958.1+20.60 (+0.70%)
As of 4 Sept 2026
Analysts lean BUY·all 1 short-term call is BUY·consensus 1–3M target ₹3,700 (25.1% above CMP)
₹3,700
25.1% above CMP
₹3,700
1 active 1–3M target
1 open
1 BUY · 0 SELL (all horizons)
N/A
6 of 10 closed calls needed
Watch GLAXO for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (7) · loading…
SELLGLAXOGlaxoSmithKline Pharmaceutic…Horizon: 1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+9.68% realised0.0% upside left
Target
₹2,600
Entry*
₹2,878.8
hit 7 Aug 2025, 12:00 am
ISICICI Securities· via Institutional / Brokerage Research68w ago
AI7+·0−-0.8% P&L+25.1% upside left
₹2,958.1
CMP
Entry*
₹2,982.5
Target
₹3,700
RBRakesh Bansal· via Zee Business (Live)2w ago
BUYGLAXOGlaxoSmithKline Pharmaceutic…Horizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI6+·2−+3.40% realised0.0% upside left
Entry*
₹2,877.3
Target
₹2,975
hit 19 Aug 2026, 9:55 am
ABAkshay Bhagwat, JM Financial· via ET Now (Live)2w ago
BUYGLAXOGlaxoSmithKline Pharmaceutic…Horizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·2−+1.34% realised0.0% upside left
SL
₹2,600
Entry*
₹2,615
Target
₹2,650
hit 28 Jul 2026, 3:30 pm
PGPrakash Gaba· via CNBC Awaaz.5w ago
BUYGLAXOGlaxoSmithKline Pharmaceutic…Horizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI7+·1−-1.71% realisedNA upside left
SL
₹3,050
Entry*
₹3,103.2
Target
₹3,200
hit 27 Aug 2026, 3:10 pm
KBKunal Bothra· via ET Now (Live)1w ago
BUYGLAXOGlaxoSmithKline Pharmaceutic…Horizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·0−-3.24% realisedNA upside left
SL
₹2,470
Entry*
₹2,552.8
Target
₹2,725
hit 24 Jul 2026, 10:00 am
KBKush Bohra· via NDTV Profit6w ago
BUYGLAXOGlaxoSmithKline Pharmaceutic…Horizon: 1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI6+·1−+6.51% realisedNA upside left
₹2,664.9
At expiry
SL
₹2,411
Entry
₹2,502
Target
₹2,700
expired 3 Aug 2026, 3:30 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram6w ago